Gene Mutation and Endometrial Cancer Hickory NC

A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments. The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women#r3 with a highly aggressive form of the disease known as endometrioid endometrial cancer.

Mobile Vet to Pet Service
(828) 446-9838
Serving Your Area
Granite Falls, NC

Data Provided by:
James Walter Goforth
(828) 431-4955
2972 N Center St
Hickory, NC
Specialty
Internal Medicine, Emergency Medicine

Data Provided by:
Samuel Timothy Bowen
(828) 325-0950
1470 9th Ave Ne
Hickory, NC
Specialty
Internal Medicine

Data Provided by:
Keith Allen Raymond
(828) 441-0888
4830 Glen Hollow Ln Ne
Hickory, NC
Specialty
Family Practice, Emergency Medicine

Data Provided by:
Michael Burton
(828) 328-2231
24 2nd Ave Ne
Hickory, NC
Specialty
Family Practice

Data Provided by:
Lincoln Chiropractic
(704) 879-1994
108 Newbold St
Lincolnton, NC

Data Provided by:
John Wilkinson
(828) 256-2112
2386 Springs Rd Ne
Hickory, NC
Specialty
Family Practice

Data Provided by:
William Thomas Smith
(828) 325-0555
50 Cloninger Mill Rd Ne
Hickory, NC
Specialty
Family Practice, Internal Medicine

Data Provided by:
Baxter Leonard
(828) 328-2231
24 2nd Ave Ne
Hickory, NC
Specialty
General Practice

Data Provided by:
Gregory Tood Brooks
(828) 304-0840
2820 16th St Ne
Hickory, NC
Specialty
Family Practice

Data Provided by:
Data Provided by:

Gene Mutation and Endometrial Cancer

Provided By:

WEDNESDAY, May 27 (HealthDay News) -- A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments.

The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women with a highly aggressive form of the disease known as endometrioid endometrial cancer.

The ATR gene directs cellular responses to DNA damage, the researchers noted.

"Women whose endometrial cancers have an ATR mutation have more than four times the risk of having their cancer return," study author Dr. Israel Zighelboim, a gynecologic oncologist, said in a news release from the university. "This and similar tumor biomarkers could potentially identify those patients most in danger of recurrence and guide the development of treatments aimed at these more aggressive tumors."

ATR mutations were found in about 5 percent of the 248 endometrioid endometrial tumor samples analyzed by the researchers. Women with ATR mutations were 4.29 times more likely to have the cancer recur after treatment and 3.88 times more likely to die.

The study appears online in the Journal of Clinical Oncology.

Zighelboim and his research colleagues plan to see if the prognostic value of ATR mutations can be confirmed in a larger group of women and to investigate the association between ATR mutations and treatment response after cancer recurrence.

More information

The American Cancer Society has more about endometrial cancer.

SOURCE: Washington University School of Medicine in St. Louis, news release, May 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com